265 related articles for article (PubMed ID: 20472470)
1. Impact of COX-2 rs5275 and rs20417 and GPIIIa rs5918 polymorphisms on 90-day ischemic stroke functional outcome: a novel finding.
Maguire J; Thakkinstian A; Levi C; Lincz L; Bisset L; Sturm J; Scott R; Whyte S; Attia J
J Stroke Cerebrovasc Dis; 2011; 20(2):134-44. PubMed ID: 20472470
[TBL] [Abstract][Full Text] [Related]
2. Day-90 acute ischemic stroke outcomes can be derived from early functional activity level.
Ovbiagele B; Saver JL
Cerebrovasc Dis; 2010; 29(1):50-6. PubMed ID: 19893312
[TBL] [Abstract][Full Text] [Related]
3. Interleukin-6 gene -174 G/C promoter polymorphism predicts severity and outcome in acute ischemic stroke patients from north India.
Chakraborty B; Chowdhury D; Vishnoi G; Goswami B; Kishore J; Agarwal S
J Stroke Cerebrovasc Dis; 2013 Jul; 22(5):683-9. PubMed ID: 22410655
[TBL] [Abstract][Full Text] [Related]
4. Association of genetic variants of fibrinolytic system with stroke and stroke subtypes.
Babu MS; Prabha TS; Kaul S; Al-Hazzani A; Shafi G; Roy S; Balakrishna N; Jyothy A; Munshi A
Gene; 2012 Mar; 495(1):76-80. PubMed ID: 22240314
[TBL] [Abstract][Full Text] [Related]
5. Rapid neurological recovery after intravenous tissue plasminogen activator in stroke: prognostic factors and outcome.
Machumpurath B; Davis SM; Yan B
Cerebrovasc Dis; 2011; 31(3):278-83. PubMed ID: 21178353
[TBL] [Abstract][Full Text] [Related]
6. Recovery after ischemic stroke: criteria for good outcome by level of disability at day 7.
Hallevi H; Albright KC; Martin-Schild SB; Barreto AD; Morales MM; Bornstein N; Ifejika NL; Shuaib A; Grotta JC; Savitz SI;
Cerebrovasc Dis; 2009; 28(4):341-8. PubMed ID: 19628935
[TBL] [Abstract][Full Text] [Related]
7. Statin use and functional outcome after tissue plasminogen activator treatment in acute ischaemic stroke.
Miedema I; Uyttenboogaart M; Koopman K; De Keyser J; Luijckx GJ
Cerebrovasc Dis; 2010 Feb; 29(3):263-7. PubMed ID: 20090317
[TBL] [Abstract][Full Text] [Related]
8. A-G-4G haplotype of PAI-1 gene polymorphisms -844 G/A, HindIII G/C, and -675 4G/5G is associated with increased risk of ischemic stroke caused by small vessel disease.
Adamski MG; Turaj W; Slowik A; Wloch-Kopec D; Wolkow P; Szczudlik A
Acta Neurol Scand; 2009 Aug; 120(2):94-100. PubMed ID: 19154538
[TBL] [Abstract][Full Text] [Related]
9. Platelet glycoprotein Ia C807T, Ib C3550T, and IIIa Pl(A1/A2) polymorphisms and ischemic stroke in young Taiwanese.
Chen CH; Lo YK; Ke D; Liu CK; Liou CW; Wu HL; Lai ML;
J Neurol Sci; 2004 Dec; 227(1):1-5. PubMed ID: 15546585
[TBL] [Abstract][Full Text] [Related]
10. The Pl(A1/A2) polymorphism of glycoprotein IIIa and cerebrovascular events in hypertension: increased risk of ischemic stroke in high-risk patients.
Lanni F; Santulli G; Izzo R; Rubattu S; Zanda B; Volpe M; Iaccarino G; Trimarco B
J Hypertens; 2007 Mar; 25(3):551-6. PubMed ID: 17278970
[TBL] [Abstract][Full Text] [Related]
11. Genetic variants in the promoter region of the ALOX5AP gene and susceptibility of ischemic stroke.
Ji R; Jia J; Ma X; Wu J; Zhang Y; Xu L
Cerebrovasc Dis; 2011; 32(3):261-8. PubMed ID: 21893978
[TBL] [Abstract][Full Text] [Related]
12. Fibrinolytic gene polymorphism and ischemic stroke.
Jood K; Ladenvall P; Tjärnlund-Wolf A; Ladenvall C; Andersson M; Nilsson S; Blomstrand C; Jern C
Stroke; 2005 Oct; 36(10):2077-81. PubMed ID: 16179568
[TBL] [Abstract][Full Text] [Related]
13. Polymorphism in the P-selectin and interleukin-4 genes as determinants of stroke: a population-based, prospective genetic analysis.
Zee RY; Cook NR; Cheng S; Reynolds R; Erlich HA; Lindpaintner K; Ridker PM
Hum Mol Genet; 2004 Feb; 13(4):389-96. PubMed ID: 14681304
[TBL] [Abstract][Full Text] [Related]
14. Cerebral white matter hyperintensities predict functional stroke outcome.
Liou LM; Chen CF; Guo YC; Cheng HL; Lee HL; Hsu JS; Lin RT; Lin HF
Cerebrovasc Dis; 2010; 29(1):22-7. PubMed ID: 19893308
[TBL] [Abstract][Full Text] [Related]
15. The COX-2 G/C -765 polymorphism may modulate the occurrence of cerebrovascular ischemia.
Colaizzo D; Fofi L; Tiscia G; Guglielmi R; Cocomazzi N; Prencipe M; Margaglione M; Toni D
Blood Coagul Fibrinolysis; 2006 Mar; 17(2):93-6. PubMed ID: 16479190
[TBL] [Abstract][Full Text] [Related]
16. The impact of imbalances in baseline stroke severity on outcome in the National Institute of Neurological Disorders and Stroke Recombinant Tissue Plasminogen Activator Stroke Study.
Kwiatkowski T; Libman R; Tilley BC; Lewandowski C; Grotta JC; Lyden P; Levine SR; Brott T;
Ann Emerg Med; 2005 Apr; 45(4):377-84. PubMed ID: 15795715
[TBL] [Abstract][Full Text] [Related]
17. Platelet polymorphisms: frequency distribution and association with coronary artery disease in an Indian population.
Ashavaid TF; Todur SP; Kondkar AA; Nair KG; Shalia KK; Dalal JJ; Rajani R; Ponde CK
Platelets; 2011; 22(2):85-91. PubMed ID: 21034162
[TBL] [Abstract][Full Text] [Related]
18. The BC genotype of the VNTR polymorphism of platelet glycoprotein Ibalpha is overrepresented in patients with recurrent stroke regardless of aspirin therapy.
Cervera A; Tàssies D; Obach V; Amaro S; Reverter JC; Chamorro A
Cerebrovasc Dis; 2007; 24(2-3):242-6. PubMed ID: 17630485
[TBL] [Abstract][Full Text] [Related]
19. Characteristics and outcome of patients with early complete neurological recovery after thrombolysis for acute ischemic stroke.
Blinzler C; Breuer L; Huttner HB; Schellinger PD; Schwab S; Köhrmann M
Cerebrovasc Dis; 2011; 31(2):185-90. PubMed ID: 21160181
[TBL] [Abstract][Full Text] [Related]
20. The plasminogen activator inhibitor-1 gene polymorphism in determining the risk of pediatric ischemic stroke--case control and family-based study.
Balcerzyk A; Żak I; Emich-Widera E; Kopyta I; Iwanicki T; Pilarska E; Pienczk-Ręcławowicz K; Kaciński M; Wendorff J; Połatyńska K
Neuropediatrics; 2011 Feb; 42(2):67-70. PubMed ID: 21647848
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
